Squar Milner Financial Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-5,786
Closed -$340K 31
2020
Q2
$340K Buy
5,786
+360
+7% +$21.5K 0.19% 132
2020
Q1
$302K Sell
5,426
-191
-3% -$11.7K 0.18% 120
2019
Q4
$360K Sell
5,617
-343
-6% -$19.6K 0.18% 121
2019
Q3
$359K Buy
5,960
+1,995
+50% +$93.8K 0.18% 137
2019
Q2
$180K Sell
3,965
-244
-6% -$11.4K 0.12% 178
2019
Q1
$200K Buy
4,209
+223
+6% +$11.1K 0.15% 166
2018
Q4
$207K Hold
3,986
0.2% 129
2018
Q3
$247K Buy
3,986
+3,669
+1,157% +$218K 0.22% 122
2018
Q2
$18K Buy
+317
New +$17.1K 0.02% 494

Other funds holding BMY

Squar Milner Financial Services's BMY Position: Q3 2020 in Review

Squar Milner Financial Services sold out of Bristol-Myers Squibb (BMY) in Q3 2020, closing a stake of 5,786 shares — an estimated $340K sold.

Squar Milner Financial Services first reported a position in BMY in Q2 2018 and held it in 9 quarters. The position peaked at $360K in Q4 2019. 2,215 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

  • Squar Milner Financial Services reported no remaining Bristol-Myers Squibb position as of Q3 2020 after selling out during the quarter.
  • Squar Milner Financial Services sold 5,786 Bristol-Myers Squibb shares in Q3 2020, an estimated $340K.
  • Squar Milner Financial Services first reported a position in Bristol-Myers Squibb in Q2 2018 and held it in 9 quarters.
  • Squar Milner Financial Services's Bristol-Myers Squibb position peaked at $360K in Q4 2019.
  • 2,215 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on Squar Milner Financial Services's 13F filing for Q3 2020.